Skip to main content

Table 4 Logistic regression estimates for the association between microvessel density (MVD) and breast biopsy diagnosis

From: Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis

Breast biopsy diagnosis

N

OR (95 % CI)a

P

Non-case

174

1.00

0.005

Case

44

1.69 (1.17–2.44)

 

Non-case

174

1.00

0.002

In situ carcinoma

36

1.36 (0.91–2.04)

 

Invasive

8

4.86 (1.91–12.38)

 

Benign

50

1.00

0.002

Proliferative

99

1.56 (1.04–2.33)

 

Proliferative with atypia

25

1.47 (0.84–2.58)

 

In situ carcinoma

36

1.89 (1.13–3.15)

 

Invasive

8

6.81 (2.52–18.42)

 

Ordinal odds ratio

 

1.66 (1.27–2.16)

0.002

  1. The average of MVD within a woman was computed and standardized by one standard deviation. Non-cases: non-proliferative benign breast disease, proliferative (ductal hyperplasia; sclerosing adenosis), proliferative with atypia (atypical ductal or lobular hyperplasia). Cases: ductal or lobular carcinoma in situ and invasive cancer
  2. aAdjusted for age at biopsy (39–44, 45–49, 50–54, 55–59, 60–65 years) and BMI (<25, 25– < 30, 30+ kg/m2)